Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ester Badia-Aranda"'
Autor:
Ester Badia Aranda, Cristina Fernández Marcos, Aida Puebla Maestu, Visitación Gozalo Marín, Raquel Vinuesa Campo, Sara Calvo Simal, Judith Gómez Camarero
Publikováno v:
Gastroenterología y Hepatología. 45:767-779
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fac623db982750e1ff8f519b01dca05
https://doi.org/10.1016/j.gastrohep.2022.02.002
https://doi.org/10.1016/j.gastrohep.2022.02.002
Autor:
Carlos Pachón Martínez, Ester Badia Aranda, Beatriz Sicilia Aladrén, Cristina Fernández Marcos, Aida Puebla Maestu, Lara Arias García, Pablo Ladrón Abia, Irene Chivato Martín-Falquina, Laura Andrés Pascual, Jorge Hernández Bernad, Judith Gómez Camarero
Publikováno v:
Gastroenterología y Hepatología. 46:S74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf66c4e01b714fe55d80bb37de9ec58d
https://doi.org/10.1016/s0210-5705(23)00174-7
https://doi.org/10.1016/s0210-5705(23)00174-7
Autor:
Ester Badia Aranda, Cristina Fernández Marcos, Aida Puebla Maestu, Visitación Gozalo Marín, Raquel Vinuesa Campo, Sara Calvo Simal, Judith Gómez Camarero
Publikováno v:
Gastroenterologia y hepatologia. 45(10)
To analyze laboratory parameters, clinical and fibrosis evolution in F3-F4 patients cured with direct-acting antivirals (DAA).Unicenteric, observational and prospective study. All F3-F4 hepatitis C patients cured with DAA from 01/11/2014 to 31/08/201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3b0cd0f19c1685c30aa9838c26084a1
https://pubmed.ncbi.nlm.nih.gov/35189262
https://pubmed.ncbi.nlm.nih.gov/35189262
Autor:
Laura Alcoba Vega, Raquel Vinuesa Campo, Francisco Jorquera Plaza, Sandra Díez Ruiz, Ester Badia Aranda, Rosa María Saiz Chumillas, Noemí Gómez Manero, Judith Gómez Camarero, Raisa Quiñones Castro
Publikováno v:
Gastroenterologia Y Hepatologia
OBJETIVO: Evaluar el resultado del cribado de hepatitis B y C en pacientes ingresados con COVID-19. PACIENTES Y MÉTODOS: Estudio transversal, prospectivo, realizado en dos hospitales españoles de tercer nivel. Se estudiaron marcadores de hepatitis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df35ac0e4420f64cbc0366abbb657249
http://europepmc.org/articles/PMC8426135
http://europepmc.org/articles/PMC8426135
Autor:
Nerma Zahiragic, Mohamed Alboraie, Daniela Reis, Suzane K. Ono, Marina Biryukova, Rakesh Kochhar, Won Kim, Mohamed El Kassas, Ling Yang, Agustina Rodil, Jacob George, Narendra Dhaka, Way Siow, Caridad Ruenes Domech, Federico Sáez-Royuela, Nadja Sivac-Burina, Mercy Karoney, Alberto Queiroz Farias, Wenfang Gui, Vasily Isakov, Johannes Kluwe, Yuanjie Yu, John Chen Hsiang, Prem Harichander Thurairajah, Fernando Bessone, Ramon Bataller, Fatma Some, Julio Vorobioff, A. Sidney Barritt, Ester Badia-Aranda, Josepmaria Argemi, Chaoqun Zhang, Helena Cortez-Pinto, Meritxell Ventura-Cots, Enrique Arús-Soler, Mariana A. Nabeshima Pharm, Sanjin Spreckic, Shiyun Tan, Ahmad Alfadhli, Andrew Wandera, Zaily Dorta Guiridi, Pedro Miguel Marques da Costa, Christoph Scheurich, Edna Solange Dos Santos Traquino, Marlen Castellanos Fernández, Flair José Carrilho, Mohamed Yacoub, Neil D. Shah, Pengbo Wu, Juan G. Abraldes, Azra Husic-Selimovic, Teo Eng-Kiong
Publikováno v:
Clin Gastroenterol Hepatol
© 2019 by the AGA Institute
Background & aims: Despite recent advances in treatment of viral hepatitis, liver-related mortality is high, possibly owing to the large burden of advanced alcohol-related liver disease (ALD). We investigated whether
Background & aims: Despite recent advances in treatment of viral hepatitis, liver-related mortality is high, possibly owing to the large burden of advanced alcohol-related liver disease (ALD). We investigated whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e8f1407d1c0573039cf0b9af6101f0e
https://hdl.handle.net/10451/56355
https://hdl.handle.net/10451/56355
Autor:
Beatriz Sicilia Aladrén, JL Martin Lorente, F Saez-Royuela Gonzalo, MA Jimenez Moreno, Gadea Hontoria Bautista, B Bernad Cabredo, Rut Pereda García, J Sanz Sanchez, S Garcia Moran, Ester Badia Aranda, Adriana Carolina Moncada Urdaneta
Publikováno v:
ESGE Days 2018 accepted abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a527bdfbfedc796d528a5b1a9b93937
https://doi.org/10.1055/s-0038-1637581
https://doi.org/10.1055/s-0038-1637581
Autor:
José Luis Martín Lorente, Huascar Alexis Ramos-Rosario, Ester Badia Aranda, Federico Sáez-Royuela, Lara Arias García, Beatriz Sicilia Aladrén
Publikováno v:
Gastroenterología y Hepatología (English Edition). 39:213-214
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f1df9a97b04352881b9c85ef81d5a4f
https://doi.org/10.1016/j.gastre.2016.02.003
https://doi.org/10.1016/j.gastre.2016.02.003
Autor:
Enrique Iglesias-Julián, Ester Badía-Aranda, Belén Bernad-Cabredo, Daniel Corrales-Cruz, María J. Romero-Arauzo
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 109, Iss 5, Pp 380-382
Terlipressin is a vasopressin analogue used in esophageal variceal bleeding and hepatorenal syndrome management. It is a safe drug with mild secondary effects. However, potentially serious ischemic complications may occur, such as cutaneous necrosis.
Externí odkaz:
https://doaj.org/article/73b3586615ff4763ba5f591cd13d79cf